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Background: In the United States, the National Center for Drug Free Sport manages the drug-testing programs for 
athletes of the National Collegiate Athletic Association (NCAA). Through its Resource Exchange Center (REC), Drug Free 
Sport supports athletic staff and athletes with information regarding drugs and dietary supplements.
Purpose: To characterize the types of drug-related and dietary supplement–related inquiries submitted to Drug Free Sport 
through the REC.
Study Design: Cross-sectional study.
Methods: All inquiries submitted to the REC for the period of September 1, 2005, through June 30, 2006, were reviewed. 
The data were categorized by the method of inquiry submission; the name of the substance in question; the sex, sport, 
and NCAA division of the athlete involved; the nature of the inquiry; and the response provided by the REC regarding the 
NCAA’s status of the substance in question.
Results: Pseudoephedrine, acetaminophen/hydrocodone, and albuterol were the most commonly self-searched medications; 
stimulants accounted for the majority of banned medications. Dietary supplements accounted for 80% of all inquiries submitted 
to the REC via the Banned Drug Inquiry Form. Among all dietary supplements, creatine was the most commonly inquired. 
Banned substances accounted for 29% of all inquiries.
Conclusions: There were more than 10 000 inquiries regarding the status of medications, dietary supplements, and other 
substances for NCAA athletes during the 2005-2006 academic year. It is helpful for athletes to have resources that help them 
navigate banned-substance lists and so avoid the inadvertent use of banned substances.
Clinical Relevance: Educating athletes regarding the stimulant content of various dietary supplements and addressing the 
lack of clinical trials to support stated claims and safety appear critical.
Keywords: athletes; student athletes; drugs; dietary supplements; medication use; stimulants; National Collegiate Athletic 
Association; Drug Free Sport
Performance-enhancing substances have been used at all levels of athletic competition.3 This use has affected Olympic athletes as well as athletes involved 
in professional and collegiate sports. Many factors may have 
contributed to this, including the rewards and fame for athletic 
success, the popularity and marketing of dietary supplements, and 
greater access to information and products sold over the Internet.6
Many sports organizations have created their own rules 
regarding the use of performance-enhancing substances, 
with each developing and maintaining their own banned-
substance list. For example, the World Anti-Doping Agency is an 
independent international agency that manages the International 
Olympic Committee’s doping control program, in addition to 
those of other national and international sports. The agency 
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maintains its own banned-substance list, which also applies 
to individual countries that affiliate.12 The United States Anti-
Doping Agency is the national organization that regulates 
the doping control program of the United States Olympic 
Committee, and it follows the World Anti-Doping Agency’s 
policies.9 National-level professional sports leagues also have 
their own regulations and distinct antidoping policies and 
banned-substance lists. An athlete who competes under the 
auspices of multiple sports-governing organizations may be 
faced with rules that indicate that a substance is banned by 
one organization but not by another for the same sport. For 
example, a college athlete who competes under the National 
Collegiate Athletic Association (NCAA) and in the Olympics 
must abide by the doping control policies of both the NCAA and 
the World Anti-Doping Agency, which have similar but different 
banned-substance lists. The use of street drugs, prescription 
medications, and nonprescription medications leads to further 
confusion about the effects of these substances on an athlete’s 
performance for a given sport. Given the widespread availability 
of these substances, it is not surprising that concerns have 
been raised about inadvertent use and the difficulty navigating 
multiple banned-substance lists. Adding to this confusion is 
the unwieldy promotion and hype of dietary supplements as a 
way to maintain health, improve strength and stamina, increase 
energy, and improve well-being. Therefore, it is not surprising 
that athletes and athletic staff would have questions regarding 
the appropriate use of these products and would need assistance 
regarding whether a substance is banned in general or banned 
for use in a given sport by a specific organization.
In the United States, the drug testing and education programs 
for collegiate athletes who participate in NCAA sports is 
managed by the National Center for Drug Free Sport. Through 
the Resource Exchange Center (REC), Drug Free Sport supports 
athletic staff and athletes with information regarding all 
medications, including street drugs and dietary supplements. 
The REC was developed with support from the NCAA in 
August 2000, and it provides a means for athletes and others 
involved in athletics to get timely, accurate information about 
medications and dietary supplements. The REC also provides 
information regarding whether a substance is banned or 
not banned by the NCAA. Today, the REC is used by other 
organizations, including the National Football League, Major 
League Baseball, the PGA Tour, and the Texas University 
Interscholastic League.
The REC is designed to accept inquiries from members of 
a subscribing organization. Inquiries submitted to the REC 
regarding a substance in question are researched to ensure 
response accuracy with respect to a substance’s banned/ 
not-banned status. Inquiries related to prescription and  
over-the counter medicines may be researched using the 
Drug Lookup feature of the REC Web site, which contains a 
populated database. For any medicines not listed in the Drug 
Lookup or for any dietary supplements, an individual inquiry 
may be submitted directly to Drug Free Sport staff online via 
the Banned Drug Inquiry Form (BDIF). Additionally, individual 
inquiries may be submitted by phone or e-mail. All inquiries are 
confidential and receive a response within 2 business days.
The REC therefore provides information about the types of 
drug-related and dietary supplement–related inquiries that are 
important to NCAA athletes and athletic staff. The purpose 
of this study is to characterize the types of inquiries and 
substances submitted to the REC by NCAA athletes or their 
athletic representatives via the Drug Lookup or the BDIF to 
help identify trends in medications and dietary supplements of 
interest in NCAA sports.
METHODS
The study was approved by the Committee on Human 
Research at the University of California, San Francisco. Data 
for the study were collected for the period of September 1, 
2005, through June 30, 2006, approximately 1 academic year. 
Data collected from the Drug Lookup database contained 
the name of the drug queried, the date, and the status of 
the drug (ie, banned or not banned by the NCAA). If a 
substance was not included in the Drug Lookup database, 
the status field would appear blank and a statement would 
advise the user to submit an inquiry to the REC via the Web 
site by completing the BDIF.
Data collected from questions submitted to the REC via the 
BDIF included the following: method of submission, athletic 
involvement of inquirer, sport, NCAA division (I, II, III), sex, 
specific question to be answered, and the response from the REC 
regarding the status of the substance (or substances) in question. 
Any other identification of the inquirers was not collected. Some 
questions involved multiple substances; for this study, an inquiry 
was defined as a question pertaining to 1 specific product, 
ingredient, or topic. With regard to athletic involvement, each 
inquirer was asked to indicate if he or she was an athlete, athletic 
trainer, director of athletics, team coach, strength coach, parent, 
or other; however, some inquirers did not indicate this, given 
that it was not a required field. Sex was tabulated only for those 
inquirers who indicated that they were athletes, because it was 
not clear if other inquirers (eg, coaches, parents) indicated their 
own sex or the sex of the athlete and because some questions 
were general and not athlete specific. Replies from the REC 
regarding substances consisted of banned, not banned, not 
specifically banned, and specifically banned for rifle. It should be 
noted that in November 2005, the NCAA status for phenylephrine 
was changed from banned to not banned. Hence, the outcome 
of the inquiry for this drug depended on the date of inquiry, 
which this study accounted for.
Only those inquiries that were in the Drug Lookup database 
and those submitted to the REC using the BDIF (via the Web site, 
e-mail, or phone) were evaluated and characterized. Data for 
both the Drug Lookup inquiries and the REC inquiries submitted 
via the BDIF were downloaded to Microsoft Access 2000 
(Microsoft Corporation, Redmond, Washington). 
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Inquiries about specific substances were classified as 
prescription medications, nonprescription medications, dietary 
supplements, street drugs, or other. Medications available 
as both prescription and nonprescription were considered 
nonprescription, unless further identification was provided 
(ie, strength or dose) to indicate otherwise. Prescription and 
nonprescription medications were further categorized by drug 
class. Dietary supplements were categorized on the basis 
of primary ingredients and known or purported effect. All 
products were categorized on the basis of the manufacturers’ 
listed ingredients at the time of the study.
RESULTS
Drug Lookup
During the 10-month study period, there were 7203 inquiries 
to the Drug Lookup system; 5290 were for prescription and 
nonprescription medications contained in the database. 
As stated above, only those inquiries that were in the 
Drug Lookup database were evaluated (prescription and 
nonprescription medications), given that the inquirer was 
instructed to submit a question via the BDIF if the substance 
was not in the database. There were an average of 529 
inquiries per month, the most occurring in November 2005 (n, 
720) and the fewest in June 2006 (n, 164).
Table 1 contains the most commonly searched medications 
in the Drug Lookup. The majority of the 5290 inquiries were 
for prescription medications (69%). In total, the medication 
in question was banned for 1375 inquiries (26%); among 
these, 75% involved prescription medications and 25% 
involved nonprescription medications. Stimulants accounted 
for the majority of banned medications. As a class, analgesics 
constituted the majority of the products searched with the 
Drug Lookup.
Banned Drug Inquiry Form
The REC received 3904 submissions through the BDIF for a 
total of 5647 individual inquiries; that is, each submission often 
contained more than 1 question or product inquiry. Twenty-
three inquiries were for products that could not be identified, 
likely because of misspelling the product or drug. The greatest 
number of banned-drug inquiries was received in September 
2005 (n, 600) and the fewest in December 2005 (n, 164).
Inquirers had the option of indicating their athletic 
involvement and 87% of the submissions included this 
information. Athletic trainers submitted the majority of 
questions (54%), followed by athletes (36%), parents (4%), 
strength coaches (3%), other (2%), team coaches (< 1%), and 
directors of athletics (< 1%). With respect to those inquirers 
who indicated that they were athletes, 79% were men, 12% 
were women, and 9% did not specify. Indicating a sport was 
also optional; however, 64% of the inquirers indicated the 
sport involved. Among these, 80% of the submissions to the 
REC were associated with football, baseball, track and field, 
basketball, and soccer. The majority of the questions posed 
to the REC were associated with Division I schools (57%), 
followed by Division II (21%) and Division III (7%); 15% of 
inquirers did not specify a division.
Inquiries regarding dietary supplements accounted for 80% of 
all inquiries using the BDIF, whereas inquiries for prescription 
and nonprescription medications composed less than 15%. 
This is consistent with the fact that the Drug Lookup contains 
prescription and nonprescription medications only. There were 
5 inquiries regarding street drugs: 4 for marijuana and 1 for 
gamma-hydroxybutyric acid. Approximately 6% of inquiries 
were miscellaneous questions, which consisted of nondrug 
topical products, shampoos, and general questions regarding 
drug testing and drug policies.
Creatine was the most common substance of inquiry among 
all based on the BDIF, either as a single ingredient or as one 
of multiple ingredients (see Table 2). The majority of dietary 
supplements that were classified as stimulants contained 
caffeine. Dietary supplements that claimed to release nitric 
oxide were common. The primary ingredient identified in 
nitric oxide dietary supplements was arginine, with glutamine 
also found as the primary ingredient in the minority of the 
nitric oxide products. Some of these products also contained 
creatine, whereas 30% contained caffeine (which was banned 
by the NCAA). Tribulus was identified as another popular 
ingredient, which constituted 38% of the inquiries regarding 
botanicals. Some of these supplements contained caffeine, 
which would put them in the banned category. There were 185 
inquiries regarding products that contained colostrum, which 
contained insulin-growth factor and other peptide hormones. 
Of the inquiries submitted through the BDIF, 550 (9.7%) 
concerned prescription medications (Table 3). Of those, 91 
(16.5%) involved stimulants such as dextroamphetamine, 
amphetamine, methylphenidate, and modafinil—all of which 
were banned by the NCAA (although medical exceptions can 
be granted for approved medical conditions). Among the 226 
inquiries regarding nonprescription medications, 17 (7.5%) 
were in the banned category. The majority of these products 
contained phenylephrine, which was removed from the banned-
drug list during the study period, as mentioned previously (note 
that 7 of 54 inquiries are categorized as banned given that they 
were made before the change in status).
The NCAA’s banned status was assessed in 5362 of the 
5647 inquiries submitted through the BDIF, which excludes 
general questions and inquiries for products that could not be 
identified. More than half of all inquiries received a response 
indicating that the product was not specifically banned by the 
NCAA. Of the 1725 inquiries involving a banned product, 1591 
(92%) were for dietary supplements, 107 (6%) for prescription 
medications, 17 (1%) for nonprescription medications, and 11 
(< 1%) for street drugs and other substances that could not be 
classified as a drug or dietary supplement (eg, topical products 
containing caffeine). The majority of inquiries regarding street 
drugs were for marijuana. The majority of banned dietary 
supplements contained banned stimulants—predominantly, 
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Table 1. Most common medications searched in Drug Lookup: September 2005 to June 2006.
No. Drug Name Inquiries: n (%) NCAA Status
 1 Pseudoephedrine 435 (8) NB
 2 Acetaminophen/hydrocodone (Vicodin, Vicodin ES, Vicodin Tuss, Vicodin HP, Lortab) 330 (6) NB
 3 Albuterol (Proventil, Ventolin, albuterol) 319 (6)
  Inhalation 214 NB
  Oral 105 B
 4 Caffeine 225 (4) B
 5 Testosterone (Androgel, Androderm, testosterone) 181 (3) B
 6 Methylphenidate (Concerta, Ritalin, Ritalin LA, Ritalin SR, methylphenidate) 169 (3) B
 7 Adderall 123 (2) B
 8 Ephedrine tannate 112 (2) B
 9 Cocaine 104 (2) B
10 Acetaminophen (acetaminophen, Tylenol, Tylenol PM) 99 (2) NB
11 Prednisone 83 (2) NB
12 Magnesium saltsa 79 (1) NB
13 Phrenilin with caffeine and codeine 70 (1) B
14 Hydrocortisoneb 63 (1) NB
15 Acetaminophen with codeine (Tylenol with codeine, acetaminophen with codeine) 62 (1) NB
15 Hydrocodone 62 (1) NB
16 Dextromethorphan 58 (1) NB
17 Codeine 57 (1) NB
18 Phenylephrine tannatec 54 (1) B/NB
18 Singulair 54 (1) NB
19 Advair 49 (< 1) NB
19 Fexofenadine (Allegra, fexofenadine) 49 (< 1) NB
19 Ibuprofen (Motrin IB, ibuprofen) 49 (< 1) NB
20 Claritin-D 45 (< 1) NB
21 Zoloft 44 (< 1) NB
22 Levalbuterol 43 (< 1) NB
23 Claritin 42 (< 1) NB
24 Methyltestosterone (Testred, methyltestosterone) 39 (< 1) B
25 Nandrolone 37 (< 1) B
Drug name is listed as indicated in the database; where multiple products and formulations were entered, the generic compound is listed first, with the 
specific product in parentheses. For products that are available with and without a prescription (e.g., different strengths or different formulations), the 
product was considered nonprescription unless the information entered by inquirer indicated the prescription product. NCAA, National Collegiate Athletic 
Association; B, banned; NB, not banned by the NCAA during the 2005-2006 academic year.
aMagnesium salts = Mg carbonate, Mg chloride, Mg gluconate, Mg hydroxide, Mg oxide.
bHydrocortisone = hydrocortisone, hydrocortisone acetate, hydrocortisone butyrate, hydrocortisone sodium phosphate, hydrocortisone valerate.
cPhenylephrine inquiry results changed on November 7, 2005, from banned to not banned status; 7 of 54 inquiries are categorized as banned.
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However, if the list of ingredients in a dietary supplement did 
not contain a banned substance, the inquirer was informed 
that the product was not specifically banned, but the following 
warning was included: “Dietary supplements are poorly 
regulated by the US FDA [Food and Drug Administration]. 
Therefore, we cannot guarantee the product’s purity or safety. 
Impure supplements can cause a positive drug test. Athletes are 
advised that the use of dietary supplements is at the user’s own 
risk.”
DISCUSSION
Our study identified that football was the most common sport 
indicated by users of the REC’s BDIF. Inquirers involved in 
other sporting events, such as baseball and track and field, 
were also common users of the REC. The months of November 
and February received the greatest number of inquiries.
Among all commonly searched medications in the Drug 
Lookup, pseudoephedrine, acetaminophen/hydrocodone 
(Vicodin), and albuterol were the most common. 
Pseudoephedrine, a sympathomimetic amine, is commonly 
used to treat nasal, sinus, and eustachian tube congestion. 
Given its popularity during the cough and cold season, 
it is not surprising that pseudoephedrine was the most 
commonly searched medication in the Drug Lookup database. 
Interestingly, pseudoephedrine was the drug involved in the 
controversy surrounding the 2000 Olympic Games, where  
all-around gymnastics champion Andrea Raducan forfeited her 
gold medal after testing positive.1
The third most commonly searched medication in the Drug 
Lookup database involved albuterol. This drug poses a unique 
challenge for athletes. Inhaled albuterol—which is commonly 
used for asthma, reactive airway disease, and other lung 
disorders—is not banned by the NCAA; however, other routes 
of albuterol administration, such as those involving the oral and 
intravenous formulations, are banned. As such, albuterol appeared 
as a common drug searched in the Drug Lookup database.
We also noted that there were more searches for prescription 
medicines than for over-the-counter medicines within the 
Drug Lookup database. Among the prescription medicines, 
stimulants accounted for the majority of the medications in the 
banned category. Indeed, the use of prescription medications 
among the US population has increased, as has the use of 
stimulant medications for medical conditions such as attention-
deficit/hyperactivity disorder and attention-deficit disorder.2 
Similar increases in stimulant medication use have been 
identified among NCAA athletes since 1997.8 College students 
with attention-deficit/hyperactivity disorder or attention-deficit 
disorder would therefore be likely candidates for using these 
medications given that concentration and attention are critical 
to doing well academically.
Athletic trainers and athletes were the most likely to submit 
questions to the REC by using the BDIF, possibly because they 
are more aware than parents and others that NCAA restrictions 
exist on performance-enhancing products. In addition, team 
Table 2. Categories of dietary supplement inquiries posed 
to the Resource Exchange Center: September 2005 to June 
2006.
Dietary Supplement Categories Inquiries, n (%)a
Creatine 1282 (28.3)
Stimulant-containing products 1137 (25.1)
Nitric oxide products 861 (19.0)
Amino acids 581 (12.8)
Whole protein products 551 (12.1)
Botanical products 504 (11.1)
Anabolic precursors 271 (6.0)
Peptide hormone analogues 236 (5.2)
Vitamins and minerals 202 (4.5)
aCombination dietary supplements were classified under multiple 
categories; total exceeds 4536, 100%.
Table 3. Most common prescription medication classes 
submitted through the Banned Drug Inquiry Form: 
September 2005 to June 2006.
Prescription Medication Classification Inquiries, n (%)a
Stimulants 91 (16.5)
Glucocorticoids 78 (14.2)
Analgesics 49 (8.9)
Antidepressants 47 (8.5)
Beta-2 agonists 41 (7.5)
Antihistamines 33 (6.0)
Antibiotics 18 (3.3)
Cough and cold 16 (2.9)
Hormone contraceptives 15 (2.7)
Anabolic agents 14 (2.5)
Muscle relaxants 12 (2.2)
Diuretics 10 (1.8)
aCombination medications were classified under multiple categories; 
total exceeds 550, 100%.
caffeine. Many of the dietary supplements involved a 
combination of ingredients; thus, if it contained a banned 
substance, then the entire product was banned by the NCAA. 
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coaches and directors of athletics were less likely to be 
inquiring about a given substance for an athlete. Male athletes 
were more likely than female athletes to use the BDIF. This 
may reflect the predominance of inquiries associated with 
male sports, such as football, rather than an indicator of sex 
differences related to medication use, abuse, or interest in 
drug use in sports. This is an area for further analysis in future 
studies.
Among the BDIF inquiries, dietary supplements were 
the most common. In 1994, Congress passed the Dietary 
Supplement Health and Education Act.11 It essentially allowed 
dietary supplements to be regulated as “food” rather than 
drugs. As such, dietary supplement manufacturers had no 
mandates to implement strict purity and potency standards, 
and they did not have to demonstrate evidence of safety or 
efficacy of their supplements in humans before marketing. 
In 2007, the Food and Drug Administration issued a final 
rule on the establishment of Good Manufacturing Practice 
standards for the dietary supplement industry.10 These 
standards will be phased in over the next few years, although 
dietary supplement formulations manufactured before the 
new standards will likely be available on store shelves until 
supplies are exhausted. It is unclear how these standards 
will apply to Internet-only dietary supplement manufacturers 
and distributors. For athletes, the inadequate regulation and 
manufacturing of dietary supplements make these products 
problematic.7 Despite better Food and Drug Administration 
oversight with regard to manufacturing, serious issues of 
supplement adulteration continue to occur, often resulting 
in the presence of unlabeled ingredients and in some cases 
contamination with prescription medications.5 Given this 
inherent lack of purity and potency, using a dietary supplement 
may pose many unknown risks to an unsuspecting athlete. 
Another problem for athletes who use dietary supplements is 
that a dietary supplement may be reformulated with a banned 
substance without any obvious disclosure on the product label 
or advertising and without the athlete’s noticing. Adding to this 
is the relative lack of access to evidence-based, high-quality 
information on dietary supplement use and safety in sports. 
For these reasons, the REC was cautious in responding to 
inquiries regarding dietary supplements and thus provided full 
disclosure of the unknown risks involved.
Among the many dietary supplement ingredients, creatine 
was the most common ingredient inquired through the 
BDIF. Creatine is purported to help increase muscle mass 
and improve strength in short-term, high-intensity anaerobic 
activities; this corresponds well to the most commonly 
indicated sport: football.4 Caffeine was the second most 
commonly identified ingredient among dietary supplement 
inquiries. This is not surprising given that caffeine is added 
to combination dietary supplements in varying amounts to 
help improve concentration, energy, and well-being and is a 
common ingredient in weight loss products.
Athletes faced with questions regarding drug use are often 
confronted with many challenges. Even if an athlete knows that 
a prescription medication or an over-the-counter medication is 
not banned for a given sport today, the medication may pose 
problems later, if it is added to or removed from the banned-
substance list. Keeping up with this information can be difficult. 
Added to this is the complexity of the administration route, 
where one formulation of a given drug is banned and another 
is not (eg, albuterol). Navigating multiple banned-substance lists 
for a given sporting event only adds to the confusion. For these 
reasons, resources and programs such as the REC can be helpful 
to athletes, sports organizations, and the medical community. 
Without access to credible and reliable information, athletes, 
athletic programs, and health care professionals would be faced 
with a daunting task of sorting through the literature and multiple 
banned-substance lists to help make educated decisions. Indeed, 
the result of having an athlete make a bad decision with regard to 
using a banned substance can have serious repercussions on the 
athlete, the athletic program, and the sporting event involved.
CONCLUSION
There were more than 10 000 inquiries regarding the 
status of medications and dietary supplements for NCAA 
athletics during the 2005-2006 academic year. Twenty-
nine percent of the time inquirers were informed that the 
substance in question was banned by the NCAA. Educating 
athletes regarding the stimulant content of various dietary 
supplements and addressing the lack of clinical trials to 
support stated claims and safety appear critical. Programs 
and resources such as the REC can be helpful to athletes, 
athletic programs, and health care professionals to avoid 
the inadvertent use of banned performance-enhancing 
substances. Periodic studies such as this one will be 
conducted to monitor for trends and to identify areas to 
target educational programs.
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